To determine the role of CD55 in vivo prostate cancer tumorigenesis and metastasis, Loberg R. et al. generated PC-3 prostate cancer cells with CD55 siRNA-targeted disruption and injected these cells in a bioluminescent SCID mouse model of metastasis. This evidence concerns the gene CD55 and prostate carcinoma.